Public-Private Partnerships and Biodefense & Pandemic Preparedness

9/14/2016

Following the devastating terrorist attacks on September 11, 2001, the United States government recognized our nation was woefully unprepared to respond to chemical, biological, radiological or nuclear (CBRN) threats. In response, Congress enacted policies intended to strengthen national biodefense and pandemic response, leveraging essential public-private partnerships to bridge the gaps in medical counter measures preparedness.

In light of current threats from terrorist organizations like ISIS, as well as threats posed by emerging diseases like Zika and Ebola, this expert panel discussion will share with Members of Congress and congressional staff the current state of biodefense and pandemic preparedness in the U.S. and explain why public-private partnerships remain critical strategies for addressing national security threats. Please join us for a timely discussion on topics like: What steps should the federal government take to support the biodefense enterprise? What federal policies should Congress undertake to ensure the nation is not caught unprepared in the event of an attack?

With introductory remarks from:
Representative Anna G. Eshoo (D-Calif.)
Representative Susan Brooks (R-Ind.)

This briefing will feature presentations and discussions from experts, including:

  • Todd Gillenwater, EVP Advocacy & External Relations, CLSA – Moderator
  • Col. Russell Coleman, PhD, U.S. Army (Ret.), immediate former Joint Project Manager, Medical Countermeasure Systems Joint Program Executive Office for Chemical & Biological Defense, U.S. Department of Defense (DoD)
  •  Asha M. George, DrPH, Co-director, Blue Ribbon Study Panel on Biodefense
  • Jennifer Bryning Alton, VP Government Affairs, Bavarian Nordic; Board Member, Alliance for Biosecurity
  • Dara Lieberman, Senior Government Relations Manager, Trust for America’s Health
What:

Biodefense & Pandemic Preparedness

When:

September 14, 2016
4:15 – 5:15 p.m. EST

Where:

2103 Rayburn House Office Building
Washington, DC

Admission:

RSVP to Meghan Drenan at (202) 743-7560 or mdrenan@califesciences.org

This event is held in strict accordance with House and Senate Ethics rules. Food and refreshments of anominal value will be provided as allowed by House Rule 25, clause 5(a)(3)(U) and Senate Rule 35.1(d)(1)